Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

SELL
$110.31 - $140.45 $281,180 - $358,007
-2,549 Reduced 18.04%
11,580 $1.31 Billion
Q1 2024

May 21, 2024

SELL
$114.22 - $140.1 $34,722 - $42,590
-304 Reduced 2.11%
14,129 $1.96 Billion
Q4 2023

Feb 16, 2024

BUY
$75.49 - $124.16 $1.09 Million - $1.79 Million
14,433 New
14,433 $1.79 Billion

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Sanibel Captiva Trust Company, Inc. Portfolio

Follow Sanibel Captiva Trust Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sanibel Captiva Trust Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sanibel Captiva Trust Company, Inc. with notifications on news.